Eli Lilly Lowers FY2026 Adj EPS Guidance from $35.50-$36.50 to $35.00-$36.00 vs $34.04 Est; Raises FY2026 Sales Guidance from $85.000B-$87.000B to $91.000B-$92.000B vs $88.848B Est
Benzinga Newsdesk 3 days ago
NewsGuidanceHot
Eli Lilly (NYSE:LLY) lowers FY2026 Adj EPS guidance from $35.50-$36.50 to $35.00-$36.00 vs $34.04 analyst estimate. Raises FY2026 sales outlook from $85.000 billion-$87.000 billion to $91.000 billion-$92.000 billion vs
Eli Lilly (NYSE:LLY) lowers FY2026 Adj EPS guidance from $35.50-$36.50 to $35.00-$36.00 vs $34.04 analyst estimate. Raises FY2026 sales outlook from $85.000 billion-$87.000 billion to $91.000 billion-$92.000 billion vs $88.848 billion estimate.